Escherichia coli O157: H7 is the predominant cause of diarrhea-associated hemolytic
uremic syndrome (HUS) worldwide. Its cardinal virulence traits are Shiga toxins, which are …

Signs and symptoms of Shiga toxin–producing Escherichia coli (STEC) serogroup O157: H7
infection range from mild gastrointestinal to bloody diarrhea and hemolytic uremic syndrome …

The ability of Shiga toxin-producing Escherichia coli (STEC) to cause severe illness in
humans is determined by multiple host factors and bacterial characteristics, including Shiga …

Variation in disease severity among Escherichia coli O157: H7 infections may result from
differential expression of Shiga toxin 2 (Stx2). Eleven strains belonging to four prominent …

We identified the mucus-activatable Shiga toxin genotype stx2d in the most common
hemolytic uremic syndrome–associated Escherichia coli serotype, O157: H7. stx2d was …

Shiga toxin-producing Escherichia coli (STEC) infections are the product of the interaction
between bacteria, phages, animals, humans, and the environment. In the late 1980s, Alberta …

Abstract Shiga toxin (Stx)–producing Escherichia coli (STEC) from patients with hemolytic-
uremic syndrome (HUS), patients with diarrhea without HUS, or asymptomatic subjects were …

Abstract Although O157: H7 Shiga toxin–producing Escherichia coli (STEC) are the
predominant cause of hemolytic-uremic syndrome (HUS) in the world, non-O157: H7 …

Escherichia coli O157: H7 strains fall into three major genetic lineages that differ in their
distribution among humans and cattle. Several recent studies have reported differences in …

The existence of two separate lineages of Escherichia coli O157: H7 has previously been
reported, and research indicates that one of these lineages (lineage I) might be more …